TOBAM’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-150
| Closed | -$57K | – | 377 |
|
|
2023
Q2 | $57K | Buy |
+150
| New | +$57K | ﹤0.01% | 349 |
|
|
2023
Q1 | – | Sell |
-72
| Closed | -$30K | – | 368 |
|
|
2022
Q4 | $30K | Sell |
72
-26
| -27% | -$10.8K | ﹤0.01% | 380 |
|
|
2022
Q3 | $41K | Hold |
98
| – | – | ﹤0.01% | 378 |
|
|
2022
Q2 | $49K | Hold |
98
| – | – | ﹤0.01% | 381 |
|
|
2022
Q1 | $55K | Buy |
98
+26
| +36% | +$14.6K | ﹤0.01% | 383 |
|
|
2021
Q4 | $54K | Hold |
72
| – | – | ﹤0.01% | 341 |
|
|
2021
Q3 | $54K | Hold |
72
| – | – | ﹤0.01% | 347 |
|
|
2021
Q2 | $46K | Hold |
72
| – | – | ﹤0.01% | 352 |
|
|
2021
Q1 | $41K | Hold |
72
| – | – | ﹤0.01% | 365 |
|
|
2020
Q4 | $42K | Hold |
72
| – | – | ﹤0.01% | 352 |
|
|
2020
Q3 | $37K | Buy |
+72
| New | +$37K | ﹤0.01% | 339 |
|